TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
79,565
|
72,117
|
35,864 |
Financial expenses |
59
|
1,751
|
2,244 |
Earnings before taxes |
24,177
|
18,707
|
6,434 |
EBITDA |
22,059
|
16,372
|
7,600 |
Total assets |
423,817
|
417,814
|
388,987 |
Current assets |
89,329
|
74,259
|
60,322 |
Current liabilities |
21,173
|
27,489
|
22,722 |
Equity capital |
391,602
|
380,692
|
350,553 |
- share capital |
230
|
228
|
248 |
Employees (average) |
249
|
227
|
121 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
92.4%
|
91.1%
|
90.1% |
Turnover per employee |
320
|
318
|
296 |
Profit as a percentage of turnover |
30.4%
|
25.9%
|
17.9% |
Return on assets (ROA) |
5.7%
|
4.9%
|
2.2% |
Current ratio |
421.9%
|
270.1%
|
265.5% |
Return on equity (ROE) |
6.2%
|
4.9%
|
1.8% |
Change turnover |
7,238
|
39,158
|
25,617 |
Change turnover % |
10%
|
119%
|
250% |
Chg. No. of employees |
22
|
106
|
64 |
Chg. No. of employees % |
10%
|
88%
|
112% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.